SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹143 Cr | ₹130 Cr | ₹196 Cr | ₹168 Cr | ₹97 Cr |
What is the latest Total Non-Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹143 Cr |
| Mar2024 | ₹130 Cr |
| Mar2023 | ₹196 Cr |
| Mar2022 | ₹168 Cr |
| Mar2017 | ₹97 Cr |
How is Total Non-Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹143 Cr | 10.34 | |
| Mar2024 | ₹130 Cr | -33.78 | |
| Mar2023 | ₹196 Cr | 16.45 | |
| Mar2022 | ₹168 Cr | 72.96 | |
| Mar2017 | ₹97 Cr | - | |
Compare Total Non-Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,147.7 Cr | -5.9% | -17.4% | -37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -5.9% |
-17.4% |
-37.4% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses